COVID-19: immunology, immunopathogenesis and potential therapies
Abstract The Coronavirus Disease-2019 (COVID-19) imposed public health emergency and
affected millions of people around the globe. As of January 2021, 100 million confirmed …
affected millions of people around the globe. As of January 2021, 100 million confirmed …
Cytokine storm induced by SARS-CoV-2
P Song, W Li, J Xie, Y Hou, C You - Clinica chimica acta, 2020 - Elsevier
Abstract Coronavirus disease 2019 (COVID-19), caused by the virus designated as severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has spread widely throughout the …
acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has spread widely throughout the …
The immune system and COVID-19: Friend or foe?
F Yazdanpanah, MR Hamblin, N Rezaei - Life sciences, 2020 - Elsevier
Abstract Aim Coronavirus disease 2019 (COVID-19) is a novel highly contagious infection
caused by SARS-CoV-2, which has been became a global public health challenge. The …
caused by SARS-CoV-2, which has been became a global public health challenge. The …
[HTML][HTML] COVID-19 signalome: Pathways for SARS-CoV-2 infection and impact on COVID-19 associated comorbidity
K Lundstrom, A Hromić-Jahjefendić, E Bilajac… - Cellular …, 2023 - Elsevier
The COVID-19 pandemic has been the focus of research the past two years. The major
breakthrough was made by discovering pathways related to SARS-CoV-2 infection through …
breakthrough was made by discovering pathways related to SARS-CoV-2 infection through …
[PDF][PDF] COVID-19: A pandemic declare by world health organization
ABSTRACT A novel coronavirus (SARS-CoV-2, currently known as 2019-nCoV) cause an
acute respiratory disease which is termed as the coronavirus disease 2019 (COVID-19) …
acute respiratory disease which is termed as the coronavirus disease 2019 (COVID-19) …
Immune-epidemiological parameters of the novel coronavirus–a perspective
A Saghazadeh, N Rezaei - Expert review of clinical immunology, 2020 - Taylor & Francis
Introduction At the end of 2019, Wuhan, a city in China with a population of about 11 million,
witnessed the outbreak of unusual pneumonia. As of 29 March 2020, the disease has …
witnessed the outbreak of unusual pneumonia. As of 29 March 2020, the disease has …
Inflammatory pathways in COVID‐19: mechanism and therapeutic interventions
Y Jiang, T Zhao, X Zhou, Y Xiang… - MedComm, 2022 - Wiley Online Library
Abstract The 2019 coronavirus disease (COVID‐19) pandemic has become a global crisis.
In the immunopathogenesis of COVID‐19, SARS‐CoV‐2 infection induces an excessive …
In the immunopathogenesis of COVID‐19, SARS‐CoV‐2 infection induces an excessive …
Severe COVID-19: a review of recent progress with a look toward the future
P Xie, W Ma, H Tang, D Liu - Frontiers in Public Health, 2020 - frontiersin.org
The novel coronavirus disease 2019 (COVID-19) is an acute infectious disease caused by
infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Currently …
infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Currently …
COVID-19: Current understanding of its Pathophysiology, Clinical presentation and Treatment
A Parasher - Postgraduate medical journal, 2021 - academic.oup.com
Background The severe acute respiratory syndrome (SARS) coronavirus-2 is a novel
coronavirus belonging to the family Coronaviridae and is now known to be responsible for …
coronavirus belonging to the family Coronaviridae and is now known to be responsible for …
Monocytes and macrophages in COVID-19: Friends and foes
S Meidaninikjeh, N Sabouni, HZ Marzouni, S Bengar… - Life sciences, 2021 - Elsevier
The COVID-19 is a novel infectious disease caused by SARS-CoV-2 and is known as a
pandemic emergency that has led to a high rate of mortality throughout the world. Evidence …
pandemic emergency that has led to a high rate of mortality throughout the world. Evidence …